Zearalenone exposure modulates the expression of ABC transporters and nuclear receptors in pregnant rats and fetal liver

Toxicology Letters

Volumn 211, Issue 3, 2012, Pages 246-256

  Koraichi, Farah ^a,b   Videmann, Bernadette ^a   Mazallon, Michelle ^a   Benahmed, Mohamed ^b   Prouillac, Caroline ^a   Lecoeur, Sylvaine ^c  

^a VETAGRO SUP   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CarMeN   (France)

Author keywords

ABC transporters; Estrogenic mycotoxin; In vivo; Nuclear receptors; Pregnancy; Zearalenone

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER C1; ABC TRANSPORTER C2; ABC TRANSPORTER C3; BREAST CANCER RESISTANCE PROTEIN; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; ZEARALENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FETUS; FETUS LIVER; GESTATIONAL AGE; LIVER TOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS, NON-STEROIDAL; FEMALE; INDICATORS AND REAGENTS; LIVER; PREGNANCY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PROGESTERONE; RNA; UTERUS; ZEARALENONE;

ANIMALIA; FUNGI; FUSARIUM; RATTUS;

EID: 84860330886     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.04.001     Document Type: Article

References (85)

1. Alcorn J., Lu X., Moscow J.A., McNamara P.J. Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. Journal of Pharmacology and Experimental Therapeutics 2002, 303(2):487-496.
2. Appelgren L.E., Arora R.G., Larsson P. Autoradiographic studies of [3H]zearalenone in mice. Toxicology 1982, 25(2-3):243-253.
3. Arceji R.J., Baas F., Raponi R., Horwitz S.B., Housman D., Croop J.M. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Molecular Reproduction and Development 1990, 25(2):101-109.
4. Axiotis C.A., Guarch R., Merino M.J., Laporte N., Neumann R.D. P-glycoprotein expression is increased in human secretory and gestational endometrium. Laboratory Investigation 1991, 65(5):577-581.
5. Axiotis C.A., Monteagudo C., Merino M.J., LaPorte N., Neumann R.D. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. American Journal of Pathology 1991, 138(4):799-806.
6. Bacha H., Chekir L., Ellouz F., Hadidane R., Creppy E.E. Effects of zearalenone on fertilization and gestation in rats. Proceedings of the UK Workshop, Occurrence and Significance of Mycotoxin 1993, 258-262. The University of West London, Central Sciences Laboratory, London. K.A. Scudamore (Ed.).
7. Bennett J.W., Klich M. Mycotoxins. Clinical Microbiology Reviews 2003, 16(3):497-516.
8. Bernhoft A., Behrens G.H., Ingebrigtsen K., Langseth W., Berndt S., Haugen T.B., Grotmol T. Placental transfer of the estrogenic mycotoxin zearalenone in rats. Reproductive Toxicology 2001, 15(5):545-550.
9. Beyer A., Hollunder J., Nasheuer H.P., Wilhelm T. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Molecular and Cellular Proteomics 2004, 3(11):1083-1092.
10. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B., Trenholm H.L. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicology and Applied Pharmacology 1993, 121(1):152-159.
11. Boehme K., Simon S., Mueller S.O. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicology and Applied Pharmacology 2009, 236(1):85-96.
12. Borst P., Evers R., Kool M., Wijnholds J.J. A family of drug transporters, the multidrug resistance-associated proteins. Journal of the National Cancer Institute 2000, 92(16):1295-1302.
13. Bovee T.F., Helsdingen R.J., Rietjens I.M., Keijer J., Hoogenboom R.L. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein, a comparison of different compounds with both receptor types. Journal of Steroid Biochemistry and Molecular Biology 2004, 91(3):99-109.
14. Bradshaw M.S., Tsai S.Y., Leng X.H., Dobson A.D., et al. Studies on the mechanism of functional cooperativity between progesterone and estrogen receptors. Journal of Biological Chemistry 1991, 266(25):16684-16690.
15. Burger H.G. Selective oestrogen receptor modulators. Hormone Research 2000, 53(Suppl. 3):25-29.
16. Cao J., Stieger B., Meier P.J., Vore M. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. American Journal of Physiology. Gastrointestinal and Liver Physiology 2002, 283(3):G757-G766.
17. Ceccatelli R., Faass O., Schlumpf M., Lichtensteiger W. Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology 2006, 220(2-3):104-116.
18. Coles L.D., Lee I.J., Voulalas P.J., Eddington N.D. Estradiol and progesterone-mediated modulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR). Molecular Pharmaceutics 2009, 6(6):1816-1825.
19. Collins T.F., Sprando R.L., Black T.N., Olejnik N., Eppley R.M., Alam H.Z., Rorie J., Ruggles D.I. Effects of zearalenone on in utero development in rats. Food and Chemical Toxicology 2006, 44(9):1455-1465.
20. Dänicke S., Swiech E., Buraczewska L., Ueberschär K.H. Kinetics and metabolism of zearalenone in young female pigs. Journal of Animal Physiology and Animal Nutrition 2005, 89(7-8):268-276.
21. Diel P., Schulz T., Smolnikar K., Strunck E., Vollmer G., Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. Journal of Steroid Biochemistry and Molecular Biology 2000, 73(1-2):1-10.
22. D'Mello J.P.F., Placinta C.M., Macdonald A.M.C. Fusarium mycotoxins, a review of global implications for animal health, welfare and productivity. Animal Feed Science and Technology 1999, 80(3-4):183-205.
23. EFSA Panel on Contaminants in the Food Chain (CONTAM) Scientific opinion on the risks for public health related to the presence of zearalenone in food. EFSA Journal 2011, 9(6):2197.
24. Enokizono J., Kusuhara H., Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Molecular Pharmacology 2007, 72(4):967-975.
25. Evseenko D.A., Paxton J.W., Keelan J.A. Independent modulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metabolism and Disposition: The Biological Fate of Chemicals 2007, 35(4):595-601.
26. Fitzpatrick D.W., Arbuckle L.D., Hassen A.M. Zearalenone metabolism and excretion in the rat: effect of different doses. Journal of Environment Science and Health. Part B: Pesticides 1988, 23(4):343-354.
27. Frizzell C., Ndossi D., Verhaegen S., Dahl E., Eriksen G., Sørlie M., Ropstad E., Muller M., Elliott C.T., Connolly L. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis. Toxicology Letters 2011, 206(2):210-217.
28. Fromm M.F. Importance of P-glycoprotein at blood-tissue barriers. Trends in Pharmacological Sciences 2004, 25(8):423-429.
29. Fukuda H., Arai M., Soh T., Yamauchi N., Hattori M.A. Progesterone regulation of the expression and function of multidrug resistance type I in porcine granulosa cells. Reproductive Toxicology 2006, 22(1):62-68.
30. Grünfeld H.T., Bonefeld-Jorgensen E.C. Effect of in vitro estrogenic pesticides on human oestrogen receptor alpha and beta mRNA levels. Toxicology Letters 2004, 151(3):467-480.
31. Guo Y., Xiao P., Lei S., Deng F., Xiao G.G., Liu Y., Chen X., Li L., Wu S., Chen Y., Jiang H., Tan L., Xie J., Zhu X., Liang S., Deng H. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochimica et Biophysica Sinica 2008, 40(5):426-436.
32. Haimeur A., Conseil G., Deeley R.G., Cole S.P.C. The MRP-related and BCRP/ABCG2 multidrug resistance proteins, biology, substrate specificity and modulation. Current Drug Metabolism 2004, 5(1):21-53.
33. Haskell S.G. Selective estrogen receptor modulators. Southern Medical Journal 2003, 96(5):469-476.
34. Heneweer M., Houtman R., Poortman J., Groot M., Maliepaard C., Peijnenburg A. Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach. Toxicological Sciences 2007, 99(1):303-314.
35. Höfer N., Diel P., Wittsiepe J., Wilhelm M., Kluxen F.M., Degen G.H. Investigations on the estrogenic activity of the metallohormone cadmium in the rat intestine. Archives of Toxicology 2010, 84(7):541-552.
36. Huls M., Russel F.G., Masereeuw R.J. The role of ATP binding cassette transporters in tissue defense and organ regeneration. Journal of Pharmacology and Experimental Therapeutics 2009, 328(1):3-9.
37. Kraus W.L., Katzenellenbogen B.S. Modulation of progesterone receptor gene expression and growth in the rat uterus, modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Endocrinology 1993, 132(6):2371-2379.
38. Kuiper G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van Der Saag P.T., Van Der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998, 139(10):4252-4263.
39. Kuiper-Goodman T., Scott P.M., Watanabe H. Risk assessment of the mycotoxin zearalenone. Regulatory Toxicology and Pharmacology 1987, 7(3):253-306.
40. Malekinejad H., Maas-Bakker R., Fink-Gremmels J. Species differences in the hepatic biotransformation of zearalenone. Veterinary Journal 2006, 172(1):96-102.
41. Marín J.J., Macías R.I., Briz O., Pérez M.J., Serrano M.A.A. Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway. Annals of Hepatology: Official Journal of the Mexican Association of Hepatology 2005, 4(2):70-76.
42. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., Bertrand-Michel J., Pineau T., Guillou H., Martin P.G., Mselli-Lakhal L. Low doses of bisphenol a induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55(2):395-407.
43. Massart F., Meucci V., Saggese G., Soldani G. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. Journal of Pediatrics 2008, 152(5):690-695.
44. Matsumoto J., Iwano H., Inoue H., Iwano N., Yamashiki N., Yokota H. Metabolic barrier against bisphenol A in rat uterine endometrium. Toxicological Sciences 2007, 99(1):118-125.
45. Minorics R., Ducza E., Márki A., Páldy E., Falkay G. Investigation of estrogen receptor alpha and beta mRNA expression in the pregnant rat uterus. Molecular Reproduction and Development 2004, 68(4):463-468.
46. Murata T., Higuchi T. Progesterone receptor mRNA levels during pregnancy, labor, lactation and the estrous cycle in rat uterus. The Journal of Reproduction and Development 2003, 49(6):425-432.
47. Nephew K.P., Long X., Osborne E., Burke K.A., Ahluwalia A., Bigsby R.M. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biology of Reproduction 2000, 62(1):168-177.
48. Nie L., Wu G., Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics 2006, 174(4):2229-2243.
49. Nishimura M., Koeda A., Suzuki E., Kawano Y., Nakayama M., Satoh T., Narimatsu S., Naito S. Modulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes. Drug Metabolism and Pharmacokinetics 2006, 21(4):297-307.
50. Nishimura M., Yamaguchi M., Yamauchi A., Ueda N., Naito S. Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and down-modulation induced by overdose of fat-free total parenteral nutrition in infant rats. Drug Metabolism and Pharmacokinetics 2005, 20(1):46-54.
51. Olsen M.E., Pettersson H.I., Sandholm K.A., Kiessling K.H. Quantitative liquid chromatographic method using fluorescence detection for determining zearalenone and its metabolites in blood plasma and urine. Journal of the Association of Official Analytical Chemists 1985, 68(4):632-635.
52. Olsen M.E., Pettersson H.I., Sandholm K., Visconti A., Kiessling K.H. Metabolism of zearalenone by sow intestinal mucosa in vitro. Food and Chemical Toxicology 1987, 25(9):681-683.
53. Owens J.W., Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists, in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Critical Reviews in Toxicology 2002, 32(6):445-520.
54. Parczyk K., Madjno R., Michna H., Nishino Y., Schneider M.R. Progesterone receptor repression by estrogens in rat uterine epithelial cells. Journal of Steroid Biochemistry and Molecular Biology 1997, 63(4-6):309-316.
55. Parveen M., Zhu Y., Kiyama R. Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes. FEBS Letters 2009, 583(14):2377-2384.
56. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 2002, 30(9):e36.
57. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001, 29(9):e45.
58. Piekarz R.L., Cohen D., Horwitz S.B. Progesterone regulates the murine multidrug resistance mdr1b gene. Journal of Biological Chemistry 1993, 268(11):7613-7616.
59. Prouillac C., Videmann B., Mazallon M., Lecoeur S. Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo). Toxicology 2009, 263(2-3):100-107.
60. Reed C.A., Berndtson A.K., Nephew K.P. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus. Anti-Cancer Drugs 2005, 16(5):559-567.
61. Sahlin L., Masironi B., Akerberg S., Eriksson H. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus. Reproductive Biology and Endocrinology 2006, 4:47.
62. Sarkadi B., Ozvegy-Laczka C., Német K., Váradi A. ABCG2 a transporter for all seasons. FEBS Letters 2004, 567(1):116-120.
63. Scotto K.W. Transcriptional modulation of ABC drug transporters. Oncogene 2003, 22(47):7496-7511.
64. Shier W.T., Shier A.C., Xie W., Mirocha C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 2001, 3(9):1435-1438.
65. Shin B.S., Hong S.H., Bulitta J.B., Hwang S.W., Kim H.J., Lee J.B., Yang S.D., Kim J.E., Yoon H.S., Kim do J., Yoo S.D. Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels. Journal of Toxicology and Environmental Health. Part A 2009, 72(21-22):1406-1411.
66. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985, 150(1):76-85.
67. St-Pierre M.V., Stallmach T., Freimoser-Grundschober A., Dufour J.F., Serrano M.A., Marin J.J., Sugiyama Y., Meier P.J. Temporal expression profiles of organic anion transport proteins in placenta and foetal liver of the rat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2004, 287(6):R1505-R1516.
68. Szuetz P., Mesterhazy A., Falkay G.Y., Bartyok T. Early telearche symptoms in children and their relations to zearalenone contamination in foodstuffs. Cereal Research Communications 1997, 25:429-436.
69. Tanaka Y., Slitt A.L., Leazer T.M., Maher J.M., Klaassen C.D. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochemical and Biophysical Research Communications 2005, 326(1):181-187.
70. Tomaszewski J., Miturski R., Semczuk A., Kotarski J., Jakowicki J. Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium. Ginekologia Polska 1998, 69(5):363-366.
71. Ueno Y., Ayaki S., Sato N., Ito T. Fate and mode of action of zearalenone. Annales de la Nutrition et de l Alimentation 1977, 31(4-6):935-948.
72. Vähäkangas K., Myllynen P. Drug transporters in the human blood-placental barrier. British Journal of Pharmacology 2009, 158(3):665-678.
73. Vendrell J.A., Magnino F., Danis E., Duchesne M.J., Pinloche S., Pons M., Birnbaum D., Nguyen C., Theillet C., Cohen P.A. Estrogen modulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. Journal of Molecular Endocrinology 2004, 32(2):397-414.
74. Videmann B., Koraichi F., Mazallon M., Lecoeur S. Effect of gender, pregnancy and exposure conditions on metabolism and distribution of zearalenone in rats. World Mycotoxin Journal 2012, 5(1):57-69.
75. Videmann B., Mazallon M., Prouillac C., Delaforge M., Lecoeur S. ABCC1, ABCC2 and ABCC3 are implicated in the transepithelial transport of the myco-estrogen zearalenone and its major metabolites. Toxicology Letters 2009, 190(2):215-223.
76. Videmann B., Mazallon M., Tep J., Lecoeur S. Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells. Food and Chemical Toxicology 2008, 46(10):3279-3286.
77. Vore M., Leggas M. Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression. Molecular Pharmacology 2008, 73(3):613-615.
78. Wang H., Lee E.W., Zhou L., Leung P.C., Ross D.D., Unadkat J.D., Mao Q. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Molecular Pharmacology 2008, 73(3):845-854.
79. Wang H., Masironi B., Eriksson H., Sahlin L. A comparative study of estrogen receptors alpha and beta in the rat uterus. Biology of Reproduction 1999, 61(4):955-964.
80. Wang H., Wu X., Hudkins K., Mikheev A., Zhang H., Gupta A., Unadkat J.D., Mao Q. Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice, effects of pregnancy and correlations with nuclear receptors. American Journal of Physiology. Endocrinology and Metabolism 2006, 291(6):E1295-E1304.
81. Wang H., Zhou L., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. American Journal of Physiology. Endocrinology and Metabolism 2006, 290(5):E798-E807.
82. Yagüe E., Armesilla A.L., Harrison G., Elliott J., Sardini A., Higgins C.F., Raguz S. P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. Journal of Biological Chemistry 2003, 278(12):10344-10352.
83. Yang C.P., DePinho S.G., Greenberger L.M., Arceci R.J., Horwitz S.B. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. Journal of Biological Chemistry 1989, 264(2):782-788.
84. Zhang Y., Zhou G., Wang H., Zhang X., Wei F., Cai Y., Yin D. Transcriptional upmodulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells. Oncology 2006, 71(5-6):446-455.
85. Zinedine A., Soriano J.M., Moltó J.C., Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, modulations and intake of zearalenone, an oestrogenic mycotoxin. Food and Chemical Toxicology 2007, 45(1):1-18.